XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Expenses    
Research and development $ 9,314 $ 6,201
General and administrative 15,908 8,152
Litigation settlement 25,000 0
Total operating expenses 50,222 14,353
Loss from operations (50,222) (14,353)
Other Income (Expense)    
Interest and other income, net 257 33
Interest expense 0 (1,492)
Net loss (49,965) (15,812)
Unrealized loss on available-for-sale securities and other (1,034) (3)
Comprehensive loss $ (50,999) $ (15,815)
Net loss per common share: basic (in dollars per share) $ (1.99) $ (0.74)
Net loss per common share: diluted (in dollars per share) $ (1.99) $ (0.74)
Weighted-average common shares outstanding: basic 25,114,453 21,253,508
Weighted-average common shares outstanding: diluted 25,114,453 21,253,508